Medical Science Liaison, Cell Therapy (NE, IA, MN, N. & S. Dakota) at Bristol-Myers Squibb

Omaha, Nebraska, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • MD, DO, PharmD, DNP, or PhD required
  • 3-5 years clinical or research experience in hematology OR 3-5 years as a medical science liaison
  • Cell therapy experience strongly preferred
  • Proven ability to work independently as well as in cross-functional networks
  • Current working knowledge of US legal, regulatory, and compliance regulations and guidelines relevant to industry interactions with health-care professionals
  • Ability to partner and maintain relationships within the medical community
  • Excellent communication, presentation and time management skills
  • Translating scientific or clinical data into understandable and valuable information to help physicians best serve their patients
  • Established personal and scientific credibility to interact with thought leaders and centers of excellence
  • Willingness to travel more than 50% in the territory (Nebraska, Iowa, Minnesota, North and South Dakota)

Responsibilities

  • Identify Key Opinion Leaders (KOLs), and establish and maintain scientific relationships with KOLs; connecting KOLs in academic and community centers
  • Act as primary liaison to investigators interested in developing and performing investigator initiated research
  • Develop and execute geography-specific Field Medical and KOL Interaction plans based on therapeutic area objectives and KOL needs
  • Provide clinical presentations and information in response to unsolicited questions (as appropriate) in academic, community, and healthcare provider settings in both group and one-on-one situations
  • Collaborate with the Clinical organization to enhance patient enrolment in BMS-sponsored clinical trials by identifying appropriate clinical trial sites and interacting with investigators in ongoing studies
  • Provide scientific support at medical congresses
  • Provide timely feedback/information on emerging clinical/scientific trends and opportunities to internal stakeholders
  • Develop and enhance professional relationships with medical thought leaders involved in various phases of product development
  • Provide medical information through scientific exchange in a fair-balanced manner and provide clinical/scientific support for Bristol Myers Squibb and the Medical Affairs department at the direction of Medical Affairs management

Skills

Cell Therapy
Key Opinion Leader Engagement
Medical Affairs
Scientific Exchange
Thought Leader Management
Clinical Support
Field-Based Medical

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI